A Synbiotic Marine Oligosaccharide Microcapsules For Enhancing Bifidobacterium Longum Survivability And Regulatory On Intestinal Probiotics

Liuyi Chan,Peng Wang,Shujuan Sun,Zhaopeng Shen,Xiaolu Jiang
DOI: https://doi.org/10.1111/ijfs.14650
2021-01-01
Abstract:A novel synbiotic multiparticulate microparticle containing alginate oligosaccharide (AOS), chitosan oligosaccharide (COS) andBifidobacterium longumCICC 6259 was produced in the current study to expand the synbiotic industrial applications. The influences of these treatments on encapsulation yield, size, morphology, protective effect and stability of microcapsules and on mice gut microbiome were studiedin vitroandin vivo.In vitroexperiments detected no significant difference (P > 0.05) in encapsulation yield with different types of microcapsules. However, the microcapsule diameter of marine oligosaccharide was approximately 60 mu m greater, and these microcapsules increased the number of surviving cells by more than 3 log cfu/g after treatment with simulated gastrointestinal juices, compared to basic alginate microcapsules.In vivo, these microcapsules significantly increased the content ofBifidobacteriumandLactobacillusand reduced the content ofEnterococcusandEscherichiain mice gut microbiome. Marine oligosaccharide probiotic microcapsules are promising as a novel functional food ingredient.
What problem does this paper attempt to address?